CapsoVision, Inc Net Income (Loss) Available to Common Stockholders, Diluted
CapsoVision, Inc (CV) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$7.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-13
- CapsoVision, Inc net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$7.48M.
- CapsoVision, Inc net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was -$7.03M.
- CapsoVision, Inc net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$7.39M.
- CapsoVision, Inc net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was -$7.92M.
- CapsoVision, Inc net income (loss) available to common stockholders, diluted for fiscal 2025 was -$25.32M.
- CapsoVision, Inc net income (loss) available to common stockholders, diluted for fiscal 2024 was -$19.90M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.48M 10-Q · filed 2026-08-13 | -$14.51M 10-Q · filed 2026-08-13 | -$21.91M derived: sum of 3 quarters · filed 2026-08-13 | -$29.83M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$7.03M 10-Q · filed 2026-05-14 | -$14.43M derived: sum of 2 quarters · filed 2026-05-14 | -$22.35M derived: sum of 3 quarters · filed 2026-05-14 | -$26.97M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$7.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$15.31M derived: sum of 2 quarters · filed 2026-03-26 | -$19.94M derived: sum of 3 quarters · filed 2026-08-13 | -$25.32M 10-K · filed 2026-03-26 |
| 2025-09-30 | -$7.92M 10-Q · filed 2025-11-13 | -$12.55M derived: sum of 2 quarters · filed 2026-08-13 | -$17.92M 10-Q · filed 2025-11-13 | -$22.56M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$4.63M 10-Q · filed 2026-08-13 | -$10.00M 10-Q · filed 2026-08-13 | -$14.64M derived: sum of 3 quarters · filed 2026-08-13 | -$20.43M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$5.38M 10-Q · filed 2026-05-14 | -$10.01M derived: sum of 2 quarters · filed 2026-05-14 | -$15.81M derived: sum of 3 quarters · filed 2026-05-14 | -$21.07M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$10.43M derived: sum of 2 quarters · filed 2026-03-26 | -$15.70M derived: sum of 3 quarters · filed 2026-03-26 | -$19.90M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$5.79M 10-Q · filed 2025-11-13 | -$11.06M derived: sum of 2 quarters · filed 2025-11-13 | -$15.26M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$5.27M 10-Q · filed 2025-08-14 | -$9.46M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |